Clinical trial
Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan
NCT01178021 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan
- Lead sponsor
- University of Oxford
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- February 28, 2014
- Enrollment
- 593 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
vivax malaria